Take Your Trading To The Next Level. Get Started Here!

Moderna says FDA delayed RSV vaccine approval to end of May

May 10, 2024 Comments Off

The FDA has not informed Moderna of any issues related to the vaccine’s safety, efficacy or quality that would prevent its approval, the biotech company said.